Endoscopic Submucosal Dissection for Gastrointestinal Neoplasms
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01378507 |
Recruitment Status
: Unknown
Verified May 2011 by Chinese PLA General Hospital.
Recruitment status was: Recruiting
First Posted
: June 22, 2011
Last Update Posted
: June 22, 2011
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Digestive System Diseases | Behavioral: endoscopic submucosal dissection | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 500 participants |
Allocation: | Randomized |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Endoscopic Submucosal Dissection for Gastrointestinal Neoplasms |
Study Start Date : | January 2009 |
Estimated Primary Completion Date : | June 2011 |
Estimated Study Completion Date : | April 2013 |

Arm | Intervention/treatment |
---|---|
Experimental: Endoscopic Submucosal Dissection
Single-arm for ESD procedure and retrospective surgical procedure(Laparoscopy, Open surgery)data collection
|
Behavioral: endoscopic submucosal dissection
ESD was carried out by using a single-channel upper gastrointestinal endoscope with a water-jet system (Q260J; Olympus Optical Co, Tokyo, Japan) and a high-frequency generator with an automatically controlled system (ENDOCUT mode) (Erbotom ICC 200; ERBE Elektromedizin GmbH, Tübingen, Germany). The transparent attachment was fitted on the tip of the endoscope mainly to obtain a constant endoscopic view and to create tension on the connective tissue for the submucosal dissection.
Other Name: Endoscopic Submucosal Dissection(ESD)
|
- The lesion result before ESD [ Time Frame: within 7 days before ESD ]Including the location, morphology and size under endoscopy and narrow banding image of lesion.
- Short-term result after ESD [ Time Frame: whithin 7 days after ESD ]Including en bloc and curative resection rate, the specimen size, complications, lateral and vertical margin exposure of tumor, and lymphatic or vascular invasion.
- The safety of ESD procedure [ Time Frame: 3months, 6months, 1year, 2years, 3years, 4years and 5years after ESD ]including the endoscopic examination at 3months, 6months, 1year, 2years, 3years, 4years and 5years after ESD

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 90 Years (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Submucosal tumor
- Mucosal tumor (T1) in patients unsuitable for surgery
Exclusion Criteria:
- Endoscopic ultrasound (EUS) or CT signs of metastasis
- Insufficient access to tumor

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01378507
Contact: Zhong-Sheng Lu, M.D. | 86-10-66937467 | lzs936150@sohu.com |
China, Beijing | |
Chinese PLA General Hospital | Recruiting |
Beijing, Beijing, China, 100853 | |
Contact: Jin Huang, M.D. lily712@vip.sina.com | |
Principal Investigator: Zhong-Sheng Lu, M.D. | |
Sub-Investigator: Jin Huang, M.D. |
Study Chair: | Zhong-Sheng Lu, M.D. | Chinese PLA General Hospital | |
Study Director: | Yun-Sheng Yang, M.D. | Chinese PLA General Hospital | |
Principal Investigator: | Jin Huang, M.D. | Chinese PLA General Hospital |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Lu Zhong-Sheng, Department of Gastroenterology and Hepatology |
ClinicalTrials.gov Identifier: | NCT01378507 History of Changes |
Other Study ID Numbers: |
20110526004 |
First Posted: | June 22, 2011 Key Record Dates |
Last Update Posted: | June 22, 2011 |
Last Verified: | May 2011 |
Keywords provided by Chinese PLA General Hospital:
endoscopic submucosal dissection gastrointestinal neoplasm |
Additional relevant MeSH terms:
Neoplasms Digestive System Diseases Gastrointestinal Diseases |
Gastrointestinal Neoplasms Digestive System Neoplasms Neoplasms by Site |